title: The expediency of cluster policy in pharmaceutical industry of Russia: An exploratory study
metadata.name: dc.contributor.author
metadata.value: Kolchinskaya, Elizaveta E.
metadata.lang: -
metadata.name: dc.contributor.author
metadata.value: Limonov, Leonid E.
metadata.lang: -
metadata.name: dc.contributor.author
metadata.value: Yakovleva, Polina E.
metadata.lang: -
metadata.name: dc.date.accessioned
metadata.value: 2019-11-26T11:54:36Z
metadata.lang: -
metadata.name: dc.date.available
metadata.value: 2019-11-26T11:54:36Z
metadata.lang: -
metadata.name: dc.date.issued
metadata.value: 2019-09
metadata.lang: -
metadata.name: dc.identifier.citation
metadata.value: Kolchinskaya E. E., Limonov L. E., Yakovleva P. E. 2019. The expediency of cluster policy in pharmaceutical industry of Russia: An exploratory study. Vestnik of Saint Petersburg University. Management 18 (3): 375–399.
metadata.lang: en_GB
metadata.name: dc.identifier.other
metadata.value: https://doi.org/10.21638/11701/spbu08.2019.303
metadata.lang: -
metadata.name: dc.identifier.uri
metadata.value: http://hdl.handle.net/11701/16642
metadata.lang: -
metadata.name: dc.description.abstract
metadata.value: Th e paper aims to study pharmaceutical clusters in Russia, which are supported by the state
  within the framework of the program for fi nancing pilot innovative territorial clusters. Th e research
  question of the investigation is to test the hypothesis that the existing concentrations of
  the pharmaceutical companies included in the support program are indeed clusters and thus
  they are susceptible to cluster policy measures. To answer this question a method of analyzing
  the networks of the enterprise groups under consideration was used. Th e data on company owners
  and contracts between the enterprises were taken from the SPARK database. Based on these
  data, networks were built refl ecting economic relations between pharmaceutical concentration
  enterprises, as well as co-ownership relations. Networks were examined for homogeneity, fragmentation
  and centrality of nodes. It was found that in many regions pharmaceutical companies have few economic ties within the group and at the same time are connected by common owners.
  Following the results of the analysis of the constructed networks, it was concluded that the pharmaceutical
  industry in the regions in question tends rather to be monopolized than have strong
  clusters of independent companies. In connection with such conditions, to promote a further
  development of the industry, it seems more justifi ed to apply antitrust, rather than cluster policies.
  Th e value of the paper is that no research of Russian cluster networks has been done before.
metadata.lang: en_GB
metadata.name: dc.language.iso
metadata.value: ru
metadata.lang: en_GB
metadata.name: dc.publisher
metadata.value: St Petersburg State University
metadata.lang: en_GB
metadata.name: dc.relation.ispartofseries
metadata.value: Vestnik of St Petersburg University. Management;Volume 18; Issue 3
metadata.lang: -
metadata.name: dc.subject
metadata.value: pharmaceutical cluster
metadata.lang: en_GB
metadata.name: dc.subject
metadata.value: cluster policy
metadata.lang: en_GB
metadata.name: dc.subject
metadata.value: industrial policy
metadata.lang: en_GB
metadata.name: dc.title
metadata.value: The expediency of cluster policy in pharmaceutical industry of Russia: An exploratory study
metadata.lang: en_GB
metadata.name: dc.type
metadata.value: Article
metadata.lang: en_GB
resources.filename: 375-399.pdf
resources.url: https://dspace.spbu.ru/bitstream/11701/16642/1/375-399.pdf
resources.format: Adobe PDF
resources.size: 2,85 MB